ZyVersa Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ZyVersa Therapeutics, Inc.
CIK #0001613083, 0001859007
EDGAR Form CIK 2011 - 2025
D [0001613083]
10-K [0001859007]
10-Q [0001859007]
3 [0001859007]
4 [0001859007]
8-K [0001859007]
SC 13D [0001859007]
SC 13G [0001859007]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Zyversa Therapeutics Inc [2025-05-15]
Anson Funds Management LP Zyversa Therapeutics Inc [2024-02-14]
L1 Capital Global Opportunities Master Fund Ltd Zyversa Therapeutics Inc [2023-07-18]
Ionic Ventures LLC Zyversa Therapeutics Inc [2023-05-03]
AGP / Alliance Global Partners LLC Zyversa Therapeutics Inc [2023-02-14]
Incon Co Ltd Zyversa Therapeutics Inc [2023-02-14]
Titcomb Shawn Zyversa Therapeutics Inc [2023-01-13]
O'Connor Daniel J Zyversa Therapeutics Inc [2022-12-22]
Glover Stephen C Zyversa Therapeutics Inc [2022-12-22]
Saba Capital Management LP Larkspur Health Acquisition Corp [2022-03-11]
View All
Form 3/4/5 Subject 2011 - 2025
ZyVersa Therapeutics, Inc.
Cashmere Karen A.
Sapirstein James
Park Min-Chul
Guzman Pablo A.
Wolfe Peter
Glover Stephen C.
Freitag Gregory Gene
Finizio Robert G
INCON Co., Ltd.
View All
Terms | Privacy | Guide
tony@aum13f.com